This paper is in the following e-collection/theme issue:

Digital Health Reviews (1724) Clinical Information and Decision Making (1915) Decision Support for Health Professionals (1539) mHealth in a Clinical Setting (743) Quality Evaluation and Descriptive Analysis/Reviews of Multiple Existing Mobile Apps (418) Pediatrics (278) Clinical Informatics (1325) ePrescribing and Innovations in Pharmacies (84) Mobile Health (mhealth) (3464)

Published on in Vol 23, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31333, first published .
CE Accreditation and Barriers to CE Marking of Pediatric Drug Calculators for Mobile Devices: Scoping Review and Qualitative Analysis

CE Accreditation and Barriers to CE Marking of Pediatric Drug Calculators for Mobile Devices: Scoping Review and Qualitative Analysis

CE Accreditation and Barriers to CE Marking of Pediatric Drug Calculators for Mobile Devices: Scoping Review and Qualitative Analysis

Authors of this article:

Charlotte Koldeweij1, 2 Author Orcid Image ;   Jonathan Clarke3 Author Orcid Image ;   Joppe Nijman4 Author Orcid Image ;   Calandra Feather1 Author Orcid Image ;   Saskia N de Wildt2, 5 Author Orcid Image ;   Nicholas Appelbaum1 Author Orcid Image
Article Authors Cited by (8) Tweetations (4) Metrics

Charlotte Koldeweij   1, 2 , MSc, MD ;   Jonathan Clarke   3 , MA, BCHIR, MPH, DPhil ;   Joppe Nijman   4 , MD, PhD ;   Calandra Feather   1 , MRES ;   Saskia N de Wildt   2, 5 , MD, PhD, Prof Dr ;   Nicholas Appelbaum   1 , MD, PhD

1 Institute of Global Health Innovation, Imperial College London, London, United Kingdom

2 Department of Pharmacology and Toxicology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

3 Centre for Mathematics of Precision Healthcare, Imperial College London, London, United Kingdom

4 Department of Pediatric Intensive Care, University Medical Centre Utrecht, Utrecht, The Netherlands

5 Intensive Care and Department of Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands

Corresponding Author:

  • Charlotte Koldeweij, MSc, MD
  • Department of Pharmacology and Toxicology
  • Radboud Institute for Health Sciences
  • Radboud University Medical Center
  • Geert Grooteplein Zuid 21
  • Nijmegen 6525 EZ
  • The Netherlands
  • Phone: 31 243616192
  • Email: charlotte.koldeweij@radboudumc.nl